Related references
Note: Only part of the references are listed.The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice
Tetsuyuki Takahashi et al.
CANCER LETTERS (2011)
Cyclooxygenase-2 in oncogenesis
Maria Teresa Rizzo
CLINICA CHIMICA ACTA (2011)
Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities
Eleni Pontiki et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Autoxidative and Cyclooxygenase-2 Catalyzed Transformation of the Dietary Chemopreventive Agent Curcumin
Markus Griesser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chemokine (C-C) motif ligand 20 is regulated by PGF(2 alpha)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation
Alison E. Wallace et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
Mary-Clare Cathcart et al.
MOLECULAR CANCER (2011)
Upregulation of the EP1 Receptor for Prostaglandin E2 Promotes Skin Tumor Progression
Inok Surh et al.
MOLECULAR CARCINOGENESIS (2011)
4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A(2) and its receptor
R-Y Huang et al.
ONCOGENE (2011)
Synthesis and evaluation of 5-lipoxygenase translocation inhibitors from acylnitroso hetero-Diels-Alder cycloadducts
Joshua K. Bolger et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Biosynthesis of hemiketal eicosanoids by cross-over of the 5-lipoxygenase and cyclooxygenase-2 pathways
Markus Griesser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Induction of apoptosis by 15d-PGJ2 via ROS formation: An alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells
Jun-Jie Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Modulation of mammary cancer cell migration by 15-deoxy-Δ12,14-prostaglandin J2: implications for anti-metastatic therapy
Anne R. Diers et al.
BIOCHEMICAL JOURNAL (2010)
Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy
Claudia Cerella et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Specialized pro-resolving lipid mediators in the inflammatory response: An update
Gerard Bannenberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis
Hidefumi Kubo et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors
Nimmanapalli P. Reddy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and biological activity of N-aroyl-tetrahydro-γ-carbolines
Alexandre Bridoux et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer
Margaret C. Keightley et al.
BMC CANCER (2010)
5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity
A. S. Fischer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: Synergistic action with LY294002, an inhibitor of phosphatidylinositol 3′-kinase
Sivalokanathan Sarveswaran et al.
CANCER LETTERS (2010)
Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth
Vivian Yvonne Shin et al.
CANCER LETTERS (2010)
White Tea Extract Induces Apoptosis in Non-Small Cell Lung Cancer Cells: the Role of Peroxisome Proliferator-Activated Receptor-γ and 15-Lipoxygenases
Jenny T. Mao et al.
CANCER PREVENTION RESEARCH (2010)
Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
Naoki Terada et al.
CANCER RESEARCH (2010)
Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
Makoto Koyama et al.
CLINICAL CANCER RESEARCH (2010)
Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB
Kin Chung Leung et al.
EXPERIMENTAL CELL RESEARCH (2010)
5-Lipoxygenase inhibitors: a review of recent developments and patents
Carlo Pergola et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis
Maozhen Tian et al.
FASEB JOURNAL (2010)
Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis
Micha P. Wasilewicz et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Lipocalin-type prostaglandin D synthase as a regulator of the retinoic acid signalling in melanocytes
Kazuhisa Takeda et al.
JOURNAL OF BIOCHEMISTRY (2010)
Prostaglandin E2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells
Shun-Fa Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cyclooxygenase-2 enhances α2β1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells
Ju-Fang Liu et al.
MOLECULAR CANCER (2010)
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Jae Il Kim et al.
MOLECULAR CANCER RESEARCH (2010)
Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities
Xinrong Ma et al.
MOLECULAR CANCER RESEARCH (2010)
Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Ying Chen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Diminished lipocalin-type prostaglandin D2 synthase expression in human lung tumors
Louis Ragolia et al.
LUNG CANCER (2010)
Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression
Robert L. Keith et al.
LUNG CANCER (2010)
Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells
Jingyan Wei et al.
LUNG CANCER (2010)
Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence
M. V. Suraneni et al.
ONCOGENE (2010)
COX-2 as a target for cancer chemotherapy
Nilanjan Ghosh et al.
PHARMACOLOGICAL REPORTS (2010)
15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer
Huiling Yuan et al.
THORAX (2010)
Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy
Nils Ole Schmidt et al.
TRANSLATIONAL ONCOLOGY (2010)
The role of prostacyclin in lung cancer
Meredith A. Tennis et al.
TRANSLATIONAL RESEARCH (2010)
Prostacyclin Inhibits Non-Small Cell Lung Cancer Growth by a Frizzled 9-Dependent Pathway That Is Blocked by Secreted Frizzled-Related Protein 1
Meredith Tennis et al.
NEOPLASIA (2010)
Selectins as Mediators of Lung Metastasis
Heinz Laubli et al.
CANCER MICROENVIRONMENT (2010)
Prognostic Role of PGE2 Receptor EP2 in Esophageal Squamous Cell Carcinoma
Kuang-Tai Kuo et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
15-Deoxi-Δ12,14-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest
Claudia Cocca et al.
BIOCHEMICAL PHARMACOLOGY (2009)
New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development
Juan J. Moreno
BIOCHEMICAL PHARMACOLOGY (2009)
Prostaglandin F2α-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway
Kurt J. Sales et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Prostaglandin F2α-F-Prostanoid Receptor Signaling Promotes Neutrophil Chemotaxis via Chemokine (C-X-C Motif) Ligand 1 in Endometrial Adenocarcinoma
Alison E. Wallace et al.
CANCER RESEARCH (2009)
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis
Hideki Amano et al.
CANCER SCIENCE (2009)
Activation of thromboxane A2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells
Xiuling Li et al.
CARCINOGENESIS (2009)
Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways
Smita Agarwal et al.
EXPERIMENTAL DERMATOLOGY (2009)
Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer
M. Barry et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2009)
Inhibition of 11 beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans
Ming-Zhi Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to γ-radiation
Anne Katrin Schauff et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Yaoyu Chen et al.
NATURE GENETICS (2009)
Effects of Lipoxin A(4) on CoCl2-Induced Angiogenesis and Its Possible Mechanisms in Human Umbilical Vein Endothelial Cells
Songjun Liu et al.
PHARMACOLOGY (2009)
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells
Hiromi Hanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma
Anna Planaguma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor
P. F. T. Cezar-de-Mello et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator-Activated Receptor γ
Raphael Nemenoff et al.
CANCER PREVENTION RESEARCH (2008)
Zyflamend® reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[α]anthracene (DMBA)-induced hamster cheek pouch model
Peiying Yang et al.
CARCINOGENESIS (2008)
15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression
Helena Viita et al.
CIRCULATION RESEARCH (2008)
Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine Model
Laleh G. Melstrom et al.
CLINICAL CANCER RESEARCH (2008)
Mouse EP3 α, β, and γ receptor variants reduce tumor cell proliferation and tumorigenesis in vivo
Ines M. Macias-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): Cyclooxygenase (COX) inhibition and beyond
P. N. Praveen Rao et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2008)
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology
Norimichi Nakahata
PHARMACOLOGY & THERAPEUTICS (2008)
Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis
Joyce E. Rundhaug et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo
Takahisa Murata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2
Bo Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Combination Therapy of PPAR gamma Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
Jordi Tauler et al.
PPAR RESEARCH (2008)
F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells
K. J. Sales et al.
ONCOGENE (2008)
Lipoxygenase metabolism: roles in tumor progression and survival
Graham P. Pidgeon et al.
CANCER AND METASTASIS REVIEWS (2007)
Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects
Giulia Corona et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer
Ralph S. Freedman et al.
CLINICAL CANCER RESEARCH (2007)
Activation of thromboxane receptor α induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells
Jingyan Wei et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells
Durga Prasad Cherukuri et al.
EXPERIMENTAL CELL RESEARCH (2007)
F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells
Kurt J. Sales et al.
ENDOCRINOLOGY (2007)
Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo
Reena Rao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells
G. Hawcroft et al.
ONCOGENE (2007)
Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells
Ioannis Stasinopoulos et al.
MOLECULAR CANCER RESEARCH (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways
Dorothea Schweiger et al.
JOURNAL OF LIPID RESEARCH (2007)
15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size)
Dean G. Tang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Current insights into the regulation of programmed cell death by NF-κB
J. Dutta et al.
ONCOGENE (2006)
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
Li Yang et al.
CANCER RESEARCH (2006)
Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells
Toyohide Hayashi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells
Daotai Nie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibition of nuclear factor-κB activation by 2′,8-biapigenin
Eun-Rhan Woo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer
WG Jiang et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: Dual inhibitors of cyclooxygenases and Lipoxygenases
PNP Rao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Elevated 12-and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases
K Nithipatikom et al.
CANCER LETTERS (2006)
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity
X Zuo et al.
ONCOGENE (2006)
Convergent oxygenation of arachidonic acid by 5-lipoxygenase and cyclooxygenase-2
C Schneider et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis
I Shureiqi et al.
CANCER RESEARCH (2005)
Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter
D Harats et al.
CANCER LETTERS (2005)
A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2α synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway
HN Jabbour et al.
ENDOCRINOLOGY (2005)
Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy
J Frigola et al.
ONCOGENE (2005)
Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
YM Sung et al.
CANCER RESEARCH (2005)
Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2
AN Hata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells
B Bhatia et al.
ONCOGENE (2005)
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
YN Ye et al.
CARCINOGENESIS (2005)
15-Deoxy Delta(12,14)-prostaglandin J(2) suppresses transcription by promoter 3 of the human thromboxane A(2) receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells
AT Coyle et al.
FEBS JOURNAL (2005)
Leukotriene A4 hydrolase as a target for cancer prevention and therapy
X Chen et al.
CURRENT CANCER DRUG TARGETS (2004)
Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
NE Kieran et al.
KIDNEY INTERNATIONAL (2004)
Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy
S Gately et al.
SEMINARS IN ONCOLOGY (2004)
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni et al.
ONCOGENE (2004)
Generation of a conditional allele of the mouse prostaglandin Ep4 receptor
A Schneider et al.
GENESIS (2004)
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice
RL Keith et al.
CANCER RESEARCH (2004)
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
Y Shoji et al.
GUT (2004)
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation
A Pozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer
CJ Witton et al.
HISTOPATHOLOGY (2004)
Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice
UP Kelavkar et al.
NEOPLASIA (2004)
15-lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer
JB Nixon et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
EP2 and EP4 prostanoid receptor signaling
JW Regan
LIFE SCIENCES (2003)
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells
I Shureiqi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor
H Hirai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
5-lipoxygenase and FLAP
M Peters-Golden et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth
H Amano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model
Y Ohashi et al.
ONCOLOGY (2003)
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells
SH Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclooxygenase, lipoxygenase and tumor angiogenesis
D Nie et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
S Fiorucci et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
RA Gupta et al.
NATURE REVIEWS CANCER (2001)
12-lipoxygenase inhibition induced apoptosis in human gastric cancer cells
BCY Wong et al.
CARCINOGENESIS (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
The contributions of cyclooxygenase-2 to tumor angiogenesis
S Gately
CANCER AND METASTASIS REVIEWS (2000)
A 12(S)-hydroxyeicosatetraenoic acid receptor interacts with steroid receptor coactivator-1
Y Kurahashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
A Rossi et al.
NATURE (2000)
Share Paper
